Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN99883695Phase 2Active, not recruiting
Phase 2, randomised, double-blind trial in myopia comparing Atropine sulfate 0.01% with Placebo eye drops (2 arms). Primary endpoint: Primary: spherical equivalent refractive error. Started Apr 2019; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN99883695.